Scott Alpard is an experienced innovator and entrepreneur with a successful track record evaluating emerging scientific discoveries and start-up and new venture development. He has over thirty years of experience in executive healthcare management and operations, medical device/product development and testing, research (basic science, translational, and clinical research) in academic medical centers, and healthcare and life science management consulting. Scott has also directed numerous medical device development and testing initiatives including creating and directing the artificial organ development program at the University of Texas Medical Branch where he published more than 125 scientific articles, abstracts, and book chapters, and has given more than 60 presentations. He has also co-founded four healthcare technology companies with two successful exits. He is currently the Chief Business Officer/Administrator for the Department of Breast Surgical Oncology at MD Anderson Cancer Center where he developed and directs surgical device and health IT innovation.
Scott has a BA from Emory University, a Master’s in Medical Science (MMSc) from the UTMB Graduate School of Biomedical Sciences, an MBA from the University of Houston, has completed the Life Science Entrepreneurship Executive Education Program at Rice University – Jesse H. Jones Graduate School of Management, and is a current PhD candidate at the University of Texas Health Science Center School of Public Health. Scott also founded and is President of The Cade R. Alpard Foundation for Pediatric Liver Disease, a 501(c)(3) non-profit organization, and is a Board Member for the American Society of Plastic Surgeons.